Research Article
Deciphering the Molecular Targets and Mechanisms of HGWD in the Treatment of Rheumatoid Arthritis via Network Pharmacology and Molecular Docking
Table 2
The binding energy of the main potential active ingredients in the HGWD formula.
| Compound | Molecular formula | Binding energy (VCAM1) | Binding energy (CTNNB1) | Binding energy (JUN) |
| Quercetin | C15H10O7 | −7.1 | −7.3 | −7.3 | Kaempferol | C15H10O6 | −7.1 | −6.5 | −7.4 | Beta-sitosterol | C29H50O | −7.3 | −7.1 | −7.8 | Formononetin | C16H12O4 | −7 | −6.3 | −6.9 | 7-O-Methylisomucronulatol | C18H20O5 | −6.7 | −6 | −6.9 | Isorhamnetin | C16H12O7 | −6.9 | −6.5 | −7.5 | Beta-carotene | C40H56 | −6.5 | −7.9 | −8.1 | Stepholidine | C19H21NO4 | −7.5 | −6.7 | −6.9 | (S)-Coclaurine | C17H19NO3 | −7.1 | −6.3 | −7.1 | Stigmasterol | C29H48O | −7.6 | −7 | −8.1 |
|
|